Last update 24 May 2025

Double-deleted Vaccinia Virus Plus CD/ SMR(SillaJen)

Overview

Basic Info

Drug Type
Oncolytic virus
Synonyms
vvDD-CDSR, JX 929, JX-929
Target
EGFR x SSTR
Action
modulators
Mechanism
EGFR modulators(Epidermal growth factor receptor erbB1 modulators), SSTR modulators(Somatostatin receptor modulators), FCY1 modulators(Cytosine deaminase modulators)
Therapeutic Areas
NeoplasmsDigestive System DisordersEndocrinology and Metabolic Disease+ [1]
Active Indication
Breast CancerColorectal CancerLiver Cancer+ [3]
Inactive Indication-
Originator Organization
SillaJen, Inc.
Active Organization
SillaJen, Inc.University of Pittsburgh Medical Center
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

100 Clinical Results associated with Double-deleted Vaccinia Virus Plus CD/ SMR(SillaJen)
Login to view more data
100 Translational Medicine associated with Double-deleted Vaccinia Virus Plus CD/ SMR(SillaJen)
Login to view more data
100 Patents (Medical) associated with Double-deleted Vaccinia Virus Plus CD/ SMR(SillaJen)
Login to view more data
100 Deals associated with Double-deleted Vaccinia Virus Plus CD/ SMR(SillaJen)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Breast CancerPhase 1-
SillaJen, Inc.
-
Breast CancerPhase 1-
University of Pittsburgh Medical Center
-
Colorectal CancerPhase 1-
University of Pittsburgh Medical Center
-
Colorectal CancerPhase 1-
SillaJen, Inc.
-
Liver CancerPhase 1-
SillaJen, Inc.
-
Liver CancerPhase 1-
University of Pittsburgh Medical Center
-
MelanomaPhase 1-
SillaJen, Inc.
-
MelanomaPhase 1-
University of Pittsburgh Medical Center
-
Pancreatic CancerPhase 1-
SillaJen, Inc.
-
Pancreatic CancerPhase 1-
University of Pittsburgh Medical Center
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free